Travere Therapeutics Inc — Cash Flow (NASDAQ:TVTX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics Dividends

Quarterly Annual

Cash from operating activities 42.74 M14.79 M186.29 M280.02 M237.47 M37.78 M 37.78 M Cash from investing activities 61.33 M137.62 M32.55 M55.78 M99.33 M27.89 M 27.89 M Cash from financing activities 127.71 M231.68 M117.57 M218.75 M139.42 M33.47 M 33.47 M Free cash flow 18.18 M-9.36 M157.73 M237.76 M201.26 M-20.37 M -20.37 M

Nouvelles

Travere Therapeutics: FILSPARI Drives Revenue, FSGS PDUFA Looms (NASDAQ:TVTX)

Travere Therapeutics, Inc. (TVTX) Q4 2025 Earnings Call Transcript

Travere Therapeutics (TVTX) Matches Q4 Earnings Estimates

Travere Therapeutics, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:TVTX) 2026-02-19

Travere Therapeutics posts surprise Q4 profit; Shares slip 5% on revenue miss

Travere Therapeutics earnings beat by $0.41, revenue fell short of estimates

Travere Therapeutics face à un test des résultats dans un contexte de retard d’approbation pour la FSGS

Walmart, Southern Co, Newmont Mining and more set to report earnings Thursday

Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?

Travere Therapeutics (TVTX) Earnings Expected to Grow: Should You Buy?

Travere Therapeutics au Sommet Guggenheim : Confiance dans la voie stratégique

Travere Therapeutics at Guggenheim Summit: Confident in Strategic Path